Green Cross Corporation (006280.KS)
KRW 168000.0
(-1.7%)
KRW 168000.0
(-1.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 724.02 Billion KRW | 25.8% |
| 2022 | 575.54 Billion KRW | -5.12% |
| 2021 | 606.57 Billion KRW | 7.09% |
| 2020 | 566.43 Billion KRW | 17.23% |
| 2019 | 483.18 Billion KRW | 46.97% |
| 2018 | 328.77 Billion KRW | 5.04% |
| 2017 | 312.98 Billion KRW | 25.77% |
| 2016 | 248.84 Billion KRW | 87.54% |
| 2015 | 132.68 Billion KRW | -17.32% |
| 2014 | 160.48 Billion KRW | 232.29% |
| 2013 | 48.29 Billion KRW | -41.16% |
| 2012 | 82.08 Billion KRW | 117.54% |
| 2011 | 37.73 Billion KRW | -42.76% |
| 2010 | 65.91 Billion KRW | -47.26% |
| 2009 | 124.98 Billion KRW | -28.74% |
| 2008 | 175.38 Billion KRW | 137.01% |
| 2007 | 74 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 897.67 Billion KRW | 10.41% |
| 2024 Q1 | 813.03 Billion KRW | 12.29% |
| 2023 Q2 | 690.23 Billion KRW | 8.17% |
| 2023 Q4 | 724.02 Billion KRW | -5.43% |
| 2023 Q3 | 765.56 Billion KRW | 10.91% |
| 2023 FY | 724.02 Billion KRW | 25.8% |
| 2023 Q1 | 638.11 Billion KRW | 10.87% |
| 2022 FY | 972.32 Billion KRW | -5.12% |
| 2022 Q4 | 575.54 Billion KRW | -12.04% |
| 2022 Q3 | 654.34 Billion KRW | -0.33% |
| 2022 Q2 | 656.49 Billion KRW | 7.75% |
| 2022 Q1 | 609.29 Billion KRW | 0.45% |
| 2021 Q2 | 654.02 Billion KRW | 4.06% |
| 2021 Q1 | 628.52 Billion KRW | 10.96% |
| 2021 Q4 | 606.57 Billion KRW | -2.5% |
| 2021 FY | 927.99 Billion KRW | 7.09% |
| 2021 Q3 | 622.13 Billion KRW | -4.88% |
| 2020 Q4 | 566.43 Billion KRW | 1.64% |
| 2020 FY | 957.48 Billion KRW | 17.23% |
| 2020 Q1 | 507.33 Billion KRW | 5.0% |
| 2020 Q2 | 579.39 Billion KRW | 14.2% |
| 2020 Q3 | 557.27 Billion KRW | -3.82% |
| 2019 Q4 | 483.18 Billion KRW | 4.98% |
| 2019 Q3 | 460.24 Billion KRW | 9.31% |
| 2019 Q1 | 387.56 Billion KRW | 17.88% |
| 2019 Q2 | 421.05 Billion KRW | 8.64% |
| 2019 FY | 855.38 Billion KRW | 46.97% |
| 2018 Q4 | 328.77 Billion KRW | -0.78% |
| 2018 Q3 | 331.36 Billion KRW | 0.38% |
| 2018 FY | 792.46 Billion KRW | 5.04% |
| 2018 Q1 | 327.74 Billion KRW | 4.72% |
| 2018 Q2 | 330.11 Billion KRW | 0.72% |
| 2017 Q4 | 312.98 Billion KRW | 0.85% |
| 2017 Q3 | 310.35 Billion KRW | -0.93% |
| 2017 FY | 691.63 Billion KRW | 25.77% |
| 2017 Q1 | 233.42 Billion KRW | -6.2% |
| 2017 Q2 | 313.27 Billion KRW | 34.21% |
| 2016 Q3 | 149.5 Billion KRW | 24.18% |
| 2016 FY | 491.02 Billion KRW | 87.54% |
| 2016 Q4 | 248.84 Billion KRW | 66.45% |
| 2016 Q1 | 228.43 Billion KRW | 72.16% |
| 2016 Q2 | 120.39 Billion KRW | -47.3% |
| 2015 Q1 | 227.48 Billion KRW | 41.76% |
| 2015 Q3 | 132.64 Billion KRW | -46.71% |
| 2015 Q4 | 132.68 Billion KRW | 0.03% |
| 2015 Q2 | 248.89 Billion KRW | 9.41% |
| 2015 FY | 337.99 Billion KRW | -17.32% |
| 2014 Q4 | 160.48 Billion KRW | -1.58% |
| 2014 Q3 | 163.05 Billion KRW | 22.76% |
| 2014 FY | 255 Billion KRW | 232.29% |
| 2014 Q1 | 116.07 Billion KRW | 140.35% |
| 2014 Q2 | 132.81 Billion KRW | 14.42% |
| 2013 Q3 | 47.17 Billion KRW | 16.47% |
| 2013 FY | 196.56 Billion KRW | -41.16% |
| 2013 Q1 | - KRW | -100.0% |
| 2013 Q2 | 40.5 Billion KRW | 0.0% |
| 2013 Q4 | 48.29 Billion KRW | 2.37% |
| 2012 Q2 | 40.45 Billion KRW | 20.9% |
| 2012 Q1 | 33.46 Billion KRW | -11.32% |
| 2012 FY | 165.05 Billion KRW | 117.54% |
| 2012 Q4 | 82.08 Billion KRW | 6.81% |
| 2012 Q3 | 76.84 Billion KRW | 89.97% |
| 2011 FY | 344.08 Billion KRW | -42.76% |
| 2011 Q4 | 37.73 Billion KRW | -45.02% |
| 2011 Q3 | 68.62 Billion KRW | 15.21% |
| 2011 Q2 | 59.56 Billion KRW | -33.59% |
| 2011 Q1 | 89.68 Billion KRW | 0.0% |
| 2010 Q1 | 115.07 Billion KRW | -7.92% |
| 2010 Q3 | 107.1 Billion KRW | 4.86% |
| 2010 FY | 264.29 Billion KRW | -47.26% |
| 2010 Q2 | 102.14 Billion KRW | -11.24% |
| 2009 Q1 | 195.68 Billion KRW | 11.57% |
| 2009 Q3 | 178.86 Billion KRW | -1.27% |
| 2009 Q2 | 181.15 Billion KRW | -7.43% |
| 2009 Q4 | 124.98 Billion KRW | -30.12% |
| 2009 FY | 208.48 Billion KRW | -28.74% |
| 2008 Q1 | 107.11 Billion KRW | 44.75% |
| 2008 Q4 | 175.38 Billion KRW | 21.81% |
| 2008 Q3 | 143.98 Billion KRW | 27.85% |
| 2008 Q2 | 112.61 Billion KRW | 5.14% |
| 2008 FY | 299.2 Billion KRW | 137.01% |
| 2007 FY | 190.24 Billion KRW | 0.0% |
| 2007 Q4 | 74 Billion KRW | -6.66% |
| 2007 Q1 | 61.92 Billion KRW | 0.0% |
| 2007 Q2 | 79.5 Billion KRW | 28.38% |
| 2007 Q3 | 79.28 Billion KRW | -0.27% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| ORIENT BIO Inc. | 3.03 Billion KRW | -23718.772% |
| Green Cross Holdings Corporation | 1280.16 Billion KRW | 43.443% |
| Green Cross Holdings Corporation | 724.02 Billion KRW | 0.0% |
| Pharmicell Co., Ltd. | 3.02 Billion KRW | -23812.975% |
| GeneOne Life Science, Inc. | 17.15 Billion KRW | -4119.343% |
| Celltrion, Inc. | 1890.42 Billion KRW | 61.7% |
| Samsung Biologics Co.,Ltd. | 1909.33 Billion KRW | 62.08% |
| SK bioscience Co.,Ltd. | 20.57 Billion KRW | -3419.191% |
| SK Biopharmaceuticals Co., Ltd. | 178.05 Billion KRW | -306.64% |
| Prestige BioPharma Limited | 89.66 Billion KRW | -707.455% |